US2002106366A1PendingUtilityA1
Composition and method for reducing gastro-intestinal distress due to alpha-D-galactoside-linked/containing sugars
Est. expiryMay 16, 2009(expired)· nominal 20-yr term from priority
Inventors:Alan E. Kligerman
A61P 1/14A23L 29/06A61K 38/47C12Y 302/01022A61K 38/46
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition is provided for ingestion by mammals for in vivo conversion of alpha-D-galactoside comprising an amount of alpha-galactosidase effective to hydrolyze alpha-D-galactoside to D-galactose, and non-toxic, ingestible excipients(s) for said alpha-galactrosidase. Gastric distress in mammals due to ingestion of foods containing alpha-D-galactoside may be reduced by ingesting the foregoing composition of alpha-galactosidase and non-toxic, ingestible excipient contemporaneously with the ingestion of said food in an amount effective to hydrolyze the alpha-D-galactoside to D-galactose.
Claims
exact text as granted — not AI-modified1 . A composition for ingestion by mammals for in vivo conversion of alpha-D-galactoside-linked sugars comprising an amount of alpha-galactosidase effective to hydrolyze alpha-D-galactoside to D-galactose, and a non-toxic, ingestible excipient for said alpha-galactosidase.
2 . A composition according to claim 1 wherein the alpha-galactosidase is present in an amount of about 870 to 2900 GalU.
3 . A composition according to claim 1 in the form of a powder for combining with food.
4 . A composition according to claim 1 in the form of a tablet.
5 . A composition according to claim 1 in liquid form.
6 . A composition according to claim 1 in soft-gel capsule form.
7 . A method of reducing gastric distress in mammals due to ingestion of food containing alpha-D-galactoside-linked sugars, comprising ingesting a composition of alpha-galactosidase and a non-toxic ingestible excipient for said alpha-galactosidase contemporaneously with the ingestion of said food in an amount effective to hydrolyze the alpha-D-galactoside to D-galactose.
8 . A method according to claim 7 wherein the alpha-galactosidase is ingested during a time period from about ¼ hour before to about ¼ hour after ingestion of the alpha-D-galactoside-containing food.
9 . A method according to claim 7 wherein said composition is administered to yield an amount of about 870 to 31,000 GalU per average flatugenic meal.
10 . A method according to claim 7 wherein said composition is ingested in the form of a powder combined with said food.
11 . A method according to claim 7 wherein said composition is ingested in tablet form.
12 . A method according to claim 7 wherein said composition is ingested in liquid form.
13 . A method according to claim 7 wherein said composition is ingested in soft-gel capsule form.Join the waitlist — get patent alerts
Track US2002106366A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.